Author Information
Aims and Scope
Medical Dosimetry aims to publish articles that will enhance the overall knowledge of the medical dosimetrist. Articles are published from the point of view not only of dosimetrists, but also of medical physicists, radiation oncologists, radiologic technologists, and other specialists. Therefore, submissions to Medical Dosimetry must concern subject matter relevant to the common field of medical dosimetry. Content should add to or improve the working knowledge of a medical dosimetrist or to the field of radiation oncology in general. Articles that do not meet these requirements will be deemed out of scope and returned without review.
Maintenance of Profile
It is the responsibility of the Author to assure all contact and personal information is current in his/her user profile. Medical Dosimetry will not assume responsibility for obtaining updated contact information for any Author. Manuscripts for which the listed Corresponding Author's information is invalid will be automatically assigned a status of "withdrawn." Failure to maintain user profiles may result in rejection of the manuscript, even after an acceptance has been issued, when a communication pathway for correspondence with the journal is required and determined by the Editor-in-Chief to be unavailable.
Category of Articles
1. Articles Category:
a. Dosimetry Contribution
b. Medical Physics Contribution
c. Clinical Radiation Oncology Contribution
It is recognized that radiation oncology is a specialty that uniquely integrates different professional aspects. As such, it is natural that many manuscripts will incorporate elements of each of the former categories. Therefore, the Corresponding Author should identify the predominant theme of the manuscript and submit it under that category.
Dosimetry Contribution: The theme of an article submitted as a Dosimetry Contribution should indicate how theory is translated into practical implementation for use by the medical dosimetrist.
Examples:
use of treatment planning involved in the research process
how new technology can be incorporated into practical treatment delivery or planning
implementation and use of new techniques
Medical Physics Contribution: The theme of an article submitted as a Medical Physics Contribution should predominantly address radiation oncology related physics theory, quality assurance, and/or subject matter that pertains to the function of a medical physicist working in radiation oncology.
Examples:
machine or beam characteristics
algorithm development or their implementation
analysis of models (physical or biological)
quality assurance mechanics, control practices, or techniques
Clinical Radiation Oncology Contribution: The theme of an article submitted as a Clinical Contribution should predominantly address how a class of patients responds to a particular treatment or technique.
Examples:
use of tumor dose limits for better tumor treatment
biological motivation or changes in outcomes due to the use of new treatment or simulation approaches
dose-related response characteristics
Article Type Submissions
2. Article Type Submissions may be in the form of a (a) Research Article, (b) Review Article, (c) Case Study, (d) Technical Note, (e) Didactic Note, or (f) Letter to the Editor. For length estimation, a rule of thumb is to divide the double-spaced manuscript text by 3 and the number of figures/tables by 4 to estimate the total count of resulting printed pages.
a) A Research Article is a report of original experimental or theoretical research. Authors should keep in mind that attention to clarity and conciseness facilitates the review process and also the impact of the published article. Limit: 10 journal pages.
b) A Review Article is an authoritative review of a subject important to the field of radiation oncology. It may be either invited or proffered. In either case, the review process will be employed. Limit: 10 journal pages.
c) A Case Study is a concise description of a technique, procedure, clinical implementation, or clinical patient-related complication of relevance to the practice of medical dosimetry. Appropriate for this article type are "tricks-of-the-trade," helpful hints to solve a specific problem, or "how-to's" on application to clinical practice. Limit: 3 journal pages.
d) A Technical Note is a brief description of a specific new development, procedure, or use of a device that offers a solution to a current specific problem and has sufficient relevance to be useful to many readers of Medical Dosimetry. Limit: 3 journal pages.
e) A Didactic Note is a short explanation of technical or clinical concepts that are specifically relevant to the practice and understanding of medical dosimetry. The Didactic Note may still present some newly measured data or a new derivation of some kind, but this must be done with pedagogic purpose in mind. These submissions should contain a brief introduction that explains why clarification of the topic is necessary. Limit: 4 journal pages.
f) A Letter to the Editor is a brief response to a published article of general interest to readers. It may be either invited or proffered. Letter must reference Medical Dosimetry articles no older than two issues from the last published volume. Limit: 1 journal page.
Ethics in publishing
Please see our information pages on Ethics in publishing and Ethical guidelines for journal publication.
Declaration of interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places: 1. A summary declaration of interest statement in the title page file (if double anonymized) or the manuscript file (if single anonymized). If there are no interests to declare then please state this: 'Declarations of interest: none'. 2. Detailed disclosures as part of a separate Declaration of Interest form, which forms part of the journal's official records. It is important for potential interests to be declared in both places and that the information matches. More information.
Prior to Publication
The submission of a manuscript with the exact same words or general premises as that of another published article is plagiarism. Authors do not have the right under any circumstances to try to double-publish any information or phrasing whatsoever in an article submitted to Medical Dosimetry. Although it is rare, such acts have been identified within the journal on different levels. The most common motive behind these types of publications involves academic advancement by increasing their professional productivity (Benos DJ, Fabres J, Farmer J, et al. Ethics and scientific publication. Advan Physiol Edu 2005;29:59-74). Authors are strongly recommended to review the types of plagiarism below, to become familiar with unacceptable practice histories, in order to avoid actions taken by the journal or through copyright litigation from other authors or researchers.
Often, plagiarism is identified on a minor level where the occurrence is when the authors were found to plagiarize words from their own prior published works. Regardless of whether or not the two articles are from the same author(s), it is an unacceptable practice occurrence. Plagiarism also comes in the form of inadequate referencing or quoting the conclusions of published papers without a link to authorship. This is a more common situation. However, it is a more serious problem for the author, because it involves other authors with copyright protected publications already in press. From this standpoint, the issue is less of a conflict professionally if it is caught during the review or editing process, because it would not have been published yet. Given the possibility of an article submission to take on a form of redundancy (repetitive ideas of the same author), duplication (double-publishing) or plagiarism (copying), such instances may result in swift and direct action, possibly prohibition from further submissions to the Journal altogether.
Medical Dosimetry and the AAMD do not tolerate plagiarism or any misrepresentation of original work. Authors found in violation of this position will be barred from further submissions to the Journal. This is a risk for not only the Corresponding Author, but to all other Co-authors on the identified manuscript as well.
Submission declaration and verification
Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service Crossref Similarity Check.
Use of inclusive language
Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.
Authorship
All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.
Rights of Co-Authors
Even though persons may have been a part of a research endeavor, they may not attest to the data being transmitted into the scientific mainstream with their name attached to it. Conversely, if the researcher was a major part of the work conducted, there should be consideration to include them as an author of the manuscript or in the Acknowledgements section. These two possibilities are to be decided upon by the Corresponding Author, who is solely responsible for every component of the manuscript submitted. The Journal does not endorse or protect authors from failure to comply with copyright laws or litigation related to publication and research credit.
The Corresponding Author shall always provide ample time for Co-authors to discuss and edit the manuscript both prior to initial submission, after every revision required, and throughout publication production processes. It is recommended that complete communication be provided to each co-author. This includes updates on submission review status and comments from the Associate Editor and/or Reviewers.
All correspondence is to be carried solely by the Corresponding Author. The Corresponding Author is responsible for ensuring that all individuals included as Co-authors have: (1) made substantial contributions to conception and design, and/or acquisition of data, and/or analysis, and/or interpretation of data; (2) drafted the article and/or revised it critically for important intellectual content, and (3) given final approval of the version to be published. All Co-authors should meet conditions (1), (2) and (3). The Corresponding Author is also responsible for ensuring that no legitimate Co-authors have been omitted. For submissions where the first author of a paper is a student or fellow, the Corresponding Author should be an experienced scientist with supervisory responsibilities.
The Corresponding Author is responsible for ensuring that the manuscript is written in clear English. For a list of companies that can offer language editing services, please see https://www.elsevier.com/languagepolishing. If English is not the first language of the Corresponding Author, he or she should seek help from a colleague for whom English is the first language to review and edit the paper before its initial submission. Articles that do not strictly adhere to the submission guidelines and format will be returned without review.
The word "significant" should be used in a manuscript only in a statistical context and should be accompanied by the results of a statistical analysis. It should not be used as a modifying adjective. As specified below, for specific article types, it may be necessary to explain the use of statistics in more detail than usual.
Changes to authorship
Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.
Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.
Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations. If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases.
For gold open access articles: Upon acceptance of an article, authors will be asked to complete a 'License Agreement' (more information). Permitted third party reuse of gold open access articles is determined by the author's choice of user license.
Author rights
As an author you (or your employer or institution) have certain rights to reuse your work. More information.
Elsevier supports responsible sharing
Find out how you can share your research published in Elsevier journals.
Role of the funding source
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.
Open access
Please visit our Open Access page for more information.
Language (usage and editing services)
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service available from Elsevier's Author Services.
Submission
Our online submission system guides you stepwise through the process of entering your article details and uploading your files. The system converts your article files to a single PDF file used in the peer-review process. Editable files (e.g., Word, LaTeX) are required to typeset your article for final publication. All correspondence, including notification of the Editor's decision and requests for revision, is sent by e-mail.
Submit your article
Please submit your article via https://www.editorialmanager.com/meddos/default.aspx.
When a revision is called for, Corresponding Authors will have three (3) months within which to submit their revision. If a revision is not submitted, the submission will be archived and rejected without further processing. For all revisions, the manuscript will be assigned a new manuscript number and considered as a new submission to the Journal. It is likely that the same Associate Editor and Reviewers will handle the revision(s).
……
更多详情:
https://www.meddos.org/content/authorinfo